Can high SHBG reduce bioavailable testosterone and blunt androgen signaling?

Sex hormone-binding globulin (SHBG) is a specialized transport protein produced by the liver that plays a central role in regulating the biological activity of sex steroids. Its ability to sequester hormones in the blood significantly influences the ratio of total hormone to bioavailable hormone.

Mechanisms of hormone binding

SHBG functions as a high-affinity carrier protein that binds testosterone and estradiol within its amino-terminal laminin G-like domain. This binding is a fundamental physiological mechanism for maintaining hormonal equilibrium.

• Affinity dynamics: Testosterone and estradiol bind to the same high-affinity pocket but in opposite orientations. Estradiol binds with a dissociation constant (Kd) of approximately 2 nM, while dihydrotestosterone (DHT)—the most potent androgen—binds even more tightly (Kd ~0.21 nM).
• Conformational changes: The binding of these hormones induces different structural changes in the SHBG dimer. Factors such as zinc ions can specifically reduce the binding affinity for estradiol by roughly 20-fold, whereas testosterone binding remains more stable.

SHBG and bioavailable hormone fractions

The relationship between SHBG and the "free" fraction of hormones follows the law of mass action. As SHBG concentrations rise, a larger percentage of the total hormone pool is bound, which directly decreases the unbound fraction available to enter target cells.

• Bioavailability: According to the "free hormone hypothesis," only the unbound or weakly albumin-bound hormones are biologically active.
• Clinical calculations: The inverse relationship is so consistent that SHBG levels are a primary variable in mathematical models (like the Vermeulen equation) used to calculate free testosterone in clinical practice.

Impact on androgen signaling

Elevated SHBG can significantly impair androgen receptor signaling, even when total hormone levels appear within the "normal" or "mildly low" reference range.

• Functional deficiency: High SHBG levels effectively mask a functional androgen deficiency at the tissue level. In clinical studies, patients frequently report symptoms of androgen deficiency—such as reduced libido, fatigue, and decreased muscle mass—when free hormone levels are low, regardless of whether their total testosterone levels are preserved.
• Perimenopausal context: In women, SHBG levels can remain high or even increase relative to declining estrogen levels. This shift further reduces the bioavailable testosterone fraction, potentially exacerbating symptoms associated with the menopause transition.

Bottom line

Higher SHBG levels reduce the bioavailable (free) fraction of testosterone and estradiol, which can diminish biological signaling and cause symptoms of hormone deficiency even when total hormone measurements remain within laboratory reference ranges.